RhumbLine Advisers’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-805
| Closed | -$1.02K | – | 4320 |
|
|
2023
Q3 | $1.02K | Hold |
805
| – | – | ﹤0.01% | 4180 |
|
|
2023
Q2 | $262 | Buy |
+805
| New | +$262 | ﹤0.01% | 4346 |
|
|
2020
Q2 | – | Sell |
-21,505
| Closed | -$82K | – | 3131 |
|
|
2020
Q1 | $82K | Hold |
21,505
| – | – | ﹤0.01% | 2812 |
|
|
2019
Q4 | $130K | Buy |
21,505
+624
| +3% | +$3.77K | ﹤0.01% | 2846 |
|
|
2019
Q3 | $158K | Buy |
20,881
+881
| +4% | +$6.67K | ﹤0.01% | 2803 |
|
|
2019
Q2 | $271K | Buy |
+20,000
| New | +$271K | ﹤0.01% | 2649 |
|
|
2018
Q2 | – | Sell |
-10,577
| Closed | -$92K | – | 2938 |
|
|
2018
Q1 | $92K | Buy |
10,577
+240
| +2% | +$2.09K | ﹤0.01% | 2753 |
|
|
2017
Q4 | $129K | Sell |
10,337
-7,252
| -41% | -$90.5K | ﹤0.01% | 2739 |
|
|
2017
Q3 | $147K | Buy |
17,589
+3,906
| +29% | +$32.6K | ﹤0.01% | 2823 |
|
|
2017
Q2 | $232K | Buy |
+13,683
| New | +$232K | ﹤0.01% | 2690 |
|